Search Legislation

Commission Implementing Regulation (EU) 2016/370Show full title

Commission Implementing Regulation (EU) 2016/370 of 15 March 2016 approving the active substance pinoxaden, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, amending the Annex to Commission Implementing Regulation (EU) No 540/2011 and allowing the Member States to extend provisional authorisations granted for that active substance (Text with EEA relevance)

 Help about what version

What Version

 Help about advanced features

Advanced Features

 Help about opening options

Opening OptionsExpand opening options

 Help about UK-EU Regulation

Legislation originating from the EU

When the UK left the EU, legislation.gov.uk published EU legislation that had been published by the EU up to IP completion day (31 December 2020 11.00 p.m.). On legislation.gov.uk, these items of legislation are kept up-to-date with any amendments made by the UK since then.

Changes over time for: ANNEX II

 Help about opening options

Version Superseded: 31/12/2020

Status:

Point in time view as at 15/03/2016.

Changes to legislation:

There are currently no known outstanding effects for the Commission Implementing Regulation (EU) 2016/370, ANNEX II. Help about Changes to Legislation

ANNEX IIU.K.

In Part B of the Annex to Implementing Regulation (EU) No 540/2011, the following entry is added:

a

Further details on identity and specification of active substance are provided in the review report.

NumberCommon Name, Identification NumbersIUPAC NamePurityaDate of approvalExpiration of approvalSpecific provisions
‘97

Pinoxaden

CAS No 243973-20-8

CIPAC No 776

8-(2,6-diethyl-p-tolyl)-1,2,4,5-tetrahydro-7-oxo-7H-pyrazolo[1,2-d][1,4,5]oxadiazepin-9-yl 2,2-dimethylpropionate

≥ 970 g/kg

Toluene max. content 1 g/kg

1 July 201630 June 2026

For the implementation of the uniform principles as referred to in Article 29(6) of Regulation (EC) No 1107/2009, the conclusions of the review report on pinoxaden, and in particular Appendices I and II thereof, as finalised in the Standing Committee on Plants, Animals, Food and Feed on 29 January 2016 shall be taken into account.

In this overall assessment Member States shall pay particular attention to the protection of groundwater, when the substance is applied in regions with vulnerable soil and/or climatic conditions.

The Member States concerned shall carry out monitoring programmes to verify potential groundwater contamination from the metabolite M2 in vulnerable zones, where appropriate.

The applicant shall submit confirmatory information as regards:

(a)

a validated method of analysis of metabolites M11, M52, M54, M55 and M56 in ground water;

(b)

the relevance of the metabolites M3, M11, M52, M54, M55 and M56, and the corresponding groundwater risk assessment, if pinoxaden is classified under Regulation (EC) No 1272/2008 as H361d (suspected of damaging the unborn child).

The applicant shall submit to the Commission, the Member States and the Authority the relevant information set out in point (a) by 30 June 2018 and the information set out in point (b) within six months from the notification of the classification decision under Regulation (EC) No 1272/2008 concerning pinoxaden.’

Back to top

Options/Help